L
Ligand Pharmaceuticals D
D
LGND
150.910
USD
-2.66
(-1.73%)
مغلق
حجم التداول
6,923
الربح لكل سهم
6
العائد الربحي
-
P/E
-37
حجم السوق
2,957,316,870
الأخبار المقالات
العنوان: Ligand Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.